Cancer Research UK, a charity funded by private donations, has published a report that claims to have found the first biological receptor that alerts the immune system to abnormal cell death, in the journal Nature.
It has been thought that this type of cell death could kick-start an immune response because an injury could be accompanied by an infection. In addition, some tumors could trigger this type of reaction, because they often have clusters of cells undergoing abnormal cell death at their core as they feed off a limited blood supply. The receptor, called DNGR-1, is found on dendritic cells, messengers that instruct T cells to attack foreign invaders.
Caetano Reis e Sousa, lead author of the study, said: "the detection of 'danger' could explain some situations when a tumor triggers an immune reaction against itself."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze